Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#61 / 200 Total
WYY - Widepoint Corp - Stock Price Chart
TickerWYY [AMEX]
CompanyWidepoint Corp
CountryUSA
IndustryInformation Technology Services
Market Cap51.85MEPS (ttm)-0.21
P/E-EPS this Y104.76%
Forward P/E21.63EPS next Y2350.00%
PEG-EPS past 5Y-
P/S0.36EPS next 5Y-
P/B3.70EPS Q/Q74.90%
Dividend-Sales Q/Q33.43%
Insider Own20.95%Inst Own13.61%
Insider Trans-1.33%Inst Trans18.77%
Short Float0.83%EarningsMay 15/a
Analyst Recom1.00Target Price6.50
Avg Volume61.12K52W Range2.19 - 6.25
WidePoint Corp. engages in the provision of Technology Management as a Service (TMaaS). The firm is involved in providing managed services for government and commercial clients that include identity management, secure mobility managed services, telecom lifecycle management, digital billing and analytics, and Information Technology as a service (ITaaS). The company was founded on May 30, 1997 and is headquartered in Fairfax, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dzyak ToddCOONov 19 '24Sale4.615,00923,091158,516Nov 20 04:46 PM
Dzyak ToddCOONov 18 '24Sale4.285912,529163,525Nov 20 04:46 PM
GEORGE ROBERT JChief Financial OfficerNov 19 '24Sale4.7822,000105,16092,474Nov 19 05:22 PM
Dzyak ToddCOOOct 01 '24Sale3.601,0003,600164,116Oct 04 05:10 PM
Dzyak ToddCOOSep 27 '24Sale3.401,0003,400165,116Oct 01 05:25 PM
TRAW - Traws Pharma Inc - Stock Price Chart
TickerTRAW [NASD]
CompanyTraws Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap5.86MEPS (ttm)-113.92
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y42.51%
P/S25.49EPS next 5Y-
P/B-EPS Q/Q550.61%
Dividend-Sales Q/Q0.00%
Insider Own26.20%Inst Own17.06%
Insider Trans0.00%Inst Trans0.52%
Short Float1.88%EarningsMay 15/b
Analyst Recom1.00Target Price6.00
Avg Volume94.39K52W Range1.05 - 19.44
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CAUTREELS WERNERChief Executive OfficerFeb 18 '25Option Exercise0.0196,348963104,348Feb 19 06:23 PM
TELO - Telomir Pharmaceuticals Inc - Stock Price Chart
TickerTELO [NASD, RUT]
CompanyTelomir Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap70.24MEPS (ttm)-0.42
P/E-EPS this Y28.57%
Forward P/E-EPS next Y10.00%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q67.50%
Dividend-Sales Q/Q-
Insider Own42.03%Inst Own12.48%
Insider Trans0.00%Inst Trans28.02%
Short Float12.94%EarningsFeb 26
Analyst Recom1.00Target Price15.25
Avg Volume167.90K52W Range2.35 - 8.40
May-15-25 08:00AM Telomir Pharmaceuticals Adds Telomir-Ag2 as a Novel Drug Candidate to Pipeline Following Breakthrough Efficacy Against MARSA and Drug-Resistant Infections, Targeting a $30B+ Antimicrobial Market Opportunity (ACCESSWIRE) -11.28%
May-07-25 08:00AM Telomir Pharmaceuticals Demonstrates Telomir-1 Reverses Key Drivers of Cellular Decline in Human Cell Lines Supporting Therapeutic Potential in Autism and Spasmodic Dysphonia (ACCESSWIRE)
Mar-19-25 08:00AM Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells (ACCESSWIRE) +5.58%
Feb-26-25 08:00AM Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines (ACCESSWIRE)
Feb-21-25 08:00AM Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market (ACCESSWIRE) -6.46%
Feb-20-25 04:01PM Telomir Pharmaceuticals Seeks To Tap Multi-Billion-Dollar Market With Breakthrough In Silver Ion Stabilization For Antibacterial Treatment, Tissue Regeneration (Benzinga)
Feb-18-25 08:00AM Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD) (ACCESSWIRE) -8.62%
Jan-28-25 08:00AM Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses (ACCESSWIRE)
Jan-07-25 08:00AM Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging) (ACCESSWIRE) +7.57%
Dec-23-24 07:30AM Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease (ACCESSWIRE) -10.04%
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm's initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ. TELOMIR-1 is under investigation to provide a potential therapeutic intervention against age-related inflammatory conditions such as hemochromatosis, as well as for post-chemotherapy recovery, by interrupting and preventing the IL-17 induced inflammatory pathways that create the systemic imbalance of cellular metals. The company was founded by Christopher C. Chapman Jr. on August 26, 2021 and is headquartered in Miami, FL.
DXF - Eason Technology Ltd. ADR - Stock Price Chart
TickerDXF [AMEX]
CompanyEason Technology Ltd. ADR
CountryChina
IndustryCredit Services
Market Cap1.26MEPS (ttm)-1779.92
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.31EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own0.78%
Insider Trans-Inst Trans-1.02%
Short Float-Earnings-
Analyst Recom-Target Price8.28
Avg Volume396.47K52W Range0.14 - 73.75
Eason Technology Ltd. engages in the provision of loan facilities to micro, small and medium size enterprises, and sole proprietors. It also offers microfinance lending services. The company was founded by Qi Ming Xu and Kang Kai Zeng on June 24, 2010 and is headquartered in Wuhan, China.
XPOF - Xponential Fitness Inc - Stock Price Chart
TickerXPOF [NYSE, RUT]
CompanyXponential Fitness Inc
CountryUSA
IndustryLeisure
Market Cap424.50MEPS (ttm)-2.03
P/E-EPS this Y675.00%
Forward P/E5.90EPS next Y98.33%
PEG-EPS past 5Y-
P/S1.34EPS next 5Y-
P/B-EPS Q/Q68.20%
Dividend-Sales Q/Q-3.32%
Insider Own23.97%Inst Own81.11%
Insider Trans-18.25%Inst Trans-1.07%
Short Float13.53%EarningsMay 08/a
Analyst Recom2.00Target Price13.30
Avg Volume859.10K52W Range6.64 - 18.95
Xponential Fitness, Inc. is a curator of boutique fitness brands across multiple verticals. It operates as a boutique fitness franchisor in the United States with studios operating across distinct brands. The company's portfolio of brands spans a variety of fitness and wellness verticals, including cycling, stretch, rowing, yoga, boxing, dance and running. Its brands include Club Pilates, Pure Barre, CycleBar, StretchLab, Row House, YogaSix Rumble, AKT, and STRIDE. The company was founded on August 11, 2017 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grabowski MarkDirectorNov 21 '24Option Exercise0.001,352,04701,352,047Nov 22 06:48 AM
Grabowski MarkDirectorNov 21 '24Sale15.352,595,59839,842,4290Nov 22 06:48 AM
Grabowski MarkDirectorNov 21 '24Proposed Sale15.351,352,04720,753,921Nov 21 06:42 AM
Hagopian AndrewChief Legal OfficerOct 10 '24Sale12.1826,740325,784255,764Oct 15 05:03 PM
Luna SarahPresidentSep 13 '24Sale13.8514,400199,381290,297Sep 16 08:07 PM
PLUG - Plug Power Inc - Stock Price Chart
TickerPLUG [NASD, RUT]
CompanyPlug Power Inc
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap754.19MEPS (ttm)-2.27
P/E-EPS this Y77.23%
Forward P/E-EPS next Y35.24%
PEG-EPS past 5Y-49.35%
P/S1.17EPS next 5Y52.69%
P/B0.37EPS Q/Q54.92%
Dividend-Sales Q/Q11.15%
Insider Own6.83%Inst Own46.84%
Insider Trans0.00%Inst Trans8.57%
Short Float25.15%EarningsMay 12/a
Analyst Recom2.81Target Price1.81
Avg Volume81.15M52W Range0.76 - 3.75
Plug Power, Inc. provides alternative energy technology, which focuses on the design, development, commercialization, and manufacture of hydrogen and fuel cell systems used primarily for the material handling and stationary power markets. Its fuel cell system solution is designed to replace lead-acid batteries in electric material handling vehicles and industrial trucks for some distribution and manufacturing businesses. The company was founded by George C. McNamee and Larry G. Garberding on June 27, 1997, and is headquartered in Slingerlands, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCNAMEE GEORGE CDirectorNov 01 '24Sale2.0910,00020,916684,782Nov 05 04:30 PM
MSSB C/FGEORGE C MCNAMEEIRA ROOfficerNov 01 '24Proposed Sale1.9610,00019,600Nov 01 04:51 PM
MCNAMEE GEORGE CDirectorAug 01 '24Sale2.3710,00023,719683,444Aug 02 04:52 PM
MSSB C/FGEORGE C MCNAMEEIRA ROOfficerAug 01 '24Proposed Sale2.4710,00024,700Aug 01 04:25 PM
UNH - Unitedhealth Group Inc - Stock Price Chart
TickerUNH [NYSE, DJIA, S&P 500]
CompanyUnitedhealth Group Inc
CountryUSA
IndustryHealthcare Plans
Market Cap248.87BEPS (ttm)23.92
P/E11.47EPS this Y-13.47%
Forward P/E9.99EPS next Y14.72%
PEG2.88EPS past 5Y1.60%
P/S0.61EPS next 5Y3.98%
P/B2.63EPS Q/Q548.50%
Dividend3.19%Sales Q/Q9.80%
Insider Own1.01%Inst Own91.85%
Insider Trans0.01%Inst Trans0.27%
Short Float0.99%EarningsApr 17/b
Analyst Recom1.59Target Price437.50
Avg Volume8.49M52W Range307.11 - 630.73
May-14-25Downgrade BofA Securities Buy → Neutral $350
May-14-25Downgrade Raymond James Strong Buy → Mkt Perform
UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
REX JOHN FPresident & CFOFeb 07 '25Option Exercise108.9725,5042,779,171191,691Feb 07 04:06 PM
FLYNN TIMOTHY PATRICKDirectorJan 17 '25Buy511.571,000511,5754,500Jan 22 04:05 PM
McSweeney ErinEVP & Chief People OfficerNov 11 '24Sale626.23701438,9877,105Nov 13 04:35 PM
McSweeney ErinOfficerNov 11 '24Proposed Sale626.23701438,987Nov 12 11:32 AM
ROOS THOMAS EChief Accounting OfficerJul 17 '24Sale569.882,8511,624,73429,501Jul 19 04:26 PM
WAI - Top KingWin Ltd - Stock Price Chart
TickerWAI [NASD]
CompanyTop KingWin Ltd
CountryChina
IndustryCapital Markets
Market Cap21.60MEPS (ttm)-0.03
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S41.53EPS next 5Y-
P/B73.33EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own42.95%Inst Own0.09%
Insider Trans0.00%Inst Trans-
Short Float0.08%Earnings-
Analyst Recom-Target Price-
Avg Volume25.28K52W Range1.90 - 20.00
May-01-25 08:00AM Top KingWin Ltd Announces 1-For-25 Reverse Share Split (GlobeNewswire) -16.40%
Apr-03-25 07:30AM Top Kingwin Ltd's Subsidiary Tiancheng Chuangxin Technology Announces its Plan to Launch Desktop Robot 1.0 - Redefining the Smart Office Companion (GlobeNewswire) -17.60%
Feb-19-25 08:00AM Top KingWin Ltd Announces $1,000,000 Convertible Promissory Note Offering and Up to $28,500,000 Additional Note Offering (GlobeNewswire)
Nov-26-24 04:05PM Top KingWin Limited Announces $2,500,000 Convertible Promissory Note Private Placement (GlobeNewswire) -19.19% +87.08%
Nov-07-24 09:28AM Top Kingwin Ltd's Subsidiary, Guji Technology, Achieves RMB 2Million in Revenue for October 2024 (GlobeNewswire) +5.31%
Oct-17-24 09:00AM Top KingWin Ltd. Announces Trading Ticker Symbol Change to WAI (GlobeNewswire)
Sep-23-24 09:42AM Top KingWin Announces Update to Supply Chain Business - Tuoxun Technology (Shenzhen) Co., Ltd. Signs A Letter of Intent with Top KingWin's Subsidiary, Guji Technology (Shenzhen) Co., Ltd. (GlobeNewswire) +10.25%
Sep-13-24 09:00AM Top KingWin's wholly owned subsidiary, Guji Technology (Shenzhen) Co., Ltd., Orders Servers to Provide Hardware Support for AI Business Development (GlobeNewswire)
Aug-29-24 09:00AM Shenzhen Tomorrow Innovation Core Technology Co., Ltd. Acquired Guji Technology, Strengthening AI Strategic Layout (GlobeNewswire)
Aug-26-24 09:00AM TCJH Establishes Shenzhen Tomorrow Innovation Core Technology Co., LTD to Lead in AI Hardware Supply Chain and Intelligent System Integration (GlobeNewswire) +14.67%
Top KingWin Ltd. is a holding company that engages in the provision of corporate business training, corporate consulting, and advisory and transaction services. It provides customized software development, technology solutions, and peripheral hardware to clients, and focusing on fields such as intelligent manufacturing, urban construction, and healthcare industry. The company was founded by Rui Lin Xu in 2020 and is headquartered in Guangzhou, China.
BQ - Boqii Holding Limited ADR - Stock Price Chart
TickerBQ [AMEX]
CompanyBoqii Holding Limited ADR
CountryChina
IndustrySpecialty Retail
Market Cap21.77MEPS (ttm)-0.92
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y41.98%
P/S0.28EPS next 5Y-
P/B0.08EPS Q/Q63.74%
Dividend-Sales Q/Q-8.13%
Insider Own13.09%Inst Own0.61%
Insider Trans0.00%Inst Trans3.05%
Short Float0.05%Earnings-
Analyst Recom1.00Target Price587.66
Avg Volume33.46K52W Range1.62 - 7.40
Boqii Holding Ltd. operates as a holding company with interest in operating online pet stores. It provides services through its subsidiaries. The company was founded by Liang Hao, Tang Yingzhi, and Chen Di in December 2007 and is headquartered in Shanghai, China.
JAGX - Jaguar Health Inc - Stock Price Chart
TickerJAGX [NASD]
CompanyJaguar Health Inc
CountryUSA
IndustryBiotechnology
Market Cap3.71MEPS (ttm)-233.19
P/E-EPS this Y81.79%
Forward P/E-EPS next Y76.14%
PEG-EPS past 5Y86.61%
P/S0.32EPS next 5Y-
P/B0.40EPS Q/Q90.02%
Dividend-Sales Q/Q52.57%
Insider Own23.32%Inst Own0.93%
Insider Trans0.00%Inst Trans-0.85%
Short Float22.01%EarningsMar 31/b
Analyst Recom1.00Target Price16.00
Avg Volume111.86K52W Range4.02 - 442.50
May-15-25 02:30PM Jaguar Health Reports First Quarter 2025 Financials (ACCESSWIRE) -10.86%
May-14-25 09:00AM Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates (ACCESSWIRE) -6.52%
May-08-25 09:30AM Jaguar Health Celebrates National Pet Cancer Awareness Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs (ACCESSWIRE) -20.95%
May-07-25 09:15AM Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts (ACCESSWIRE)
Apr-30-25 08:15AM Proof-of-Concept Results Show Crofelemer Reduced Total Parenteral Nutrition in Patients with Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) by up to 27% and 12.5% - Potential to Modify Disease Progression in Intestinal Failure Patients (ACCESSWIRE)
Apr-28-25 08:15AM Jaguar Health to Present Initial Results from the Proof-of-Concept Study of Crofelemer for the Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) During an April 30 Investor Webcast (ACCESSWIRE)
Apr-17-25 09:00AM Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health's Crofelemer to be Presented at April 2025 ELITE PED-GI Congress (ACCESSWIRE)
Apr-16-25 09:50AM Jaguar Health to present results from OnTarget study in breast cancer patients (TipRanks) +9.81%
Apr-15-25 09:30AM Jaguar Health Announces Significant Results in Breast Cancer Patients Accepted for Presentation at Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting (ACCESSWIRE)
Apr-08-25 08:30AM Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product (ACCESSWIRE)
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
12345678910111220